Sperogenix
曙方
elsewhere's corpus does not cover Sperogenix as a subject in its own right. The only mentions appear in background references to other companies' partnerships — specifically, Triastek's collaborations with "礼来、默克、勃林格殷格翰、西门子、曙方" (Lilly, Merck, Boehringer Ingelheim, Siemens, and Sperogenix) , where Sperogenix is listed among multinational and domestic pharmaceutical partners. No entity card or dedicated coverage describes what Sperogenix is, when it was founded, its focus, or its scale.
AI-generated — may contain errors, please verify.
SperogenixCompany
曙方
渲染中…
Mentioned in 3 articles
Coverage
Over $1.2 Billion in Total Value: Triastek Announces First-Ever Technology Platform International Collaboration in Chinese Pharmaceutical History with BioNTech | Yunqi Capital
Empowering Digital Transformation in Pharmaceutical Development
"Triastek" Closes 150 Million Yuan Pre-C Round to Accelerate Commercialization of 3D-Printed Drugs | Yunqi Capital
Pioneering a New Era of Intelligent Drug Discovery
How Can a "3D Printer" Boost Productivity in the Pharmaceutical Industry? | The B-Side of Entrepreneurship
Take the hard, meaningful path


